GrADe : what is “ quality of evidence ” and why is it important to clinicians ? rATING quALITY of evIDeNCe AND STreNGTH of reCommeNDATIoNS

Guideline developers use a bewildering variety of systems to rate the quality of the evidence underlying their recommendations. Some are facile, some confused, and others sophisticated but complex

[1]  Rebecca S. Graves,et al.  Users' Guides to the Medical Literature: A Manual for Evidence-Based Clinical Practice. , 2002 .

[2]  G. Guyatt,et al.  The Pylorus: Take It or Leave It? Systematic Review and Meta-Analysis of Pylorus-Preserving versus Standard Whipple Pancreaticoduodenectomy for Pancreatic or Periampullary Cancer , 2007, Annals of Surgical Oncology.

[3]  Michael K Gould,et al.  An official ATS statement: grading the quality of evidence and strength of recommendations in ATS guidelines and recommendations. , 2006, American journal of respiratory and critical care medicine.

[4]  G. Raskob,et al.  Hemorrhagic complications of anticoagulant treatment. , 2004, Chest.

[5]  Deborah M Caldwell,et al.  Simultaneous comparison of multiple treatments: combining direct and indirect evidence , 2005, BMJ : British Medical Journal.

[6]  F. R. Rosendaal,et al.  Thromboembolic and Bleeding Complications in Patients With Mechanical Heart Valve Prostheses , 1994, Circulation.

[7]  Andrew D Oxman,et al.  Improving the use of research evidence in guideline development , 2007 .

[8]  G. Guyatt,et al.  Users' guides to the medical literature. , 1993, JAMA.

[9]  J. Cox,et al.  Differences between perspectives of physicians and patients on anticoagulation in patients with atrial fibrillation: observational study. , 2001, BMJ : British Medical Journal.

[10]  B. Chong,et al.  Prospective Randomised Open-label Comparison of Danaparoid with Dextran 70 in the Treatment of Heparin-induced Thrombocytopaenia with Thrombosis , 2001, Thrombosis and Haemostasis.

[11]  A. Oxman,et al.  Improving the use of research evidence in guideline development: 10. Integrating values and consumer involvement , 2006, Health research policy and systems.

[12]  Gordon H Guyatt,et al.  Randomized trials stopped early for benefit: a systematic review. , 2005, JAMA.

[13]  J. Ioannidis,et al.  Completeness of safety reporting in randomized trials: an evaluation of 7 medical areas. , 2001, JAMA.

[14]  Mohit Bhandari,et al.  Patients at the centre: in our practice, and in our use of language , 2004, ACP journal club.

[15]  G H Guyatt,et al.  Guidelines for reading literature reviews. , 1988, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[16]  G. Guyatt,et al.  Grading quality of evidence and strength of recommendations , 2004, BMJ : British Medical Journal.

[17]  A. Avins,et al.  Brief Communication: Better Ways To Question Patients about Adverse Medical Events , 2006, Annals of Internal Medicine.

[18]  J. Ioannidis,et al.  Better Reporting of Harms in Randomized Trials: An Extension of the CONSORT Statement , 2004, Annals of Internal Medicine.

[19]  G. Guyatt,et al.  Users' Guides to the Medical Literature: XXV. Evidence-based medicine: principles for applying the Users' Guides to patient care. Evidence-Based Medicine Working Group. , 2000, JAMA.

[20]  S. Fletcher,et al.  Approach of the Canadian Task Force to the Periodic Health Examination. , 1980, Annals of internal medicine.

[21]  G. Guyatt,et al.  Meta‐analysis of flavonoids for the treatment of haemorrhoids , 2006, The British journal of surgery.

[22]  Paul Glasziou,et al.  When are randomised trials unnecessary? Picking signal from noise , 2007, BMJ : British Medical Journal.

[23]  Gordon H Guyatt,et al.  Comparison of mortality between private for-profit and private not-for-profit hemodialysis centers: a systematic review and meta-analysis. , 2002, JAMA.

[24]  John P A Ioannidis,et al.  Improving Safety Reporting from Randomised Trials , 2002, Drug safety.

[25]  Gordon H. Guyatt,et al.  Users' Guides to the Medical Literature: A Manual for Evidence-Based Clinical Practice; Users' Guides to the Medical Literature: Essentials of Evidence-Based Clinical Practice , 2003, BMJ : British Medical Journal.

[26]  D. Thompson,et al.  Cochrane Review : Helmets for preventing head and facial injuries in bicyclists , 2017 .

[27]  A. Laupacis,et al.  Preference-Based Antithrombotic Therapy in Atrial Fibrillation: Implications for Clinical Decision Making , 2005, Medical decision making : an international journal of the Society for Medical Decision Making.